Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × obinutuzumab × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 28 Lymphoma, Follicular 16 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, Mantle-Cell 6 Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia 3 Neoplasms 2 Bronchiolitis Obliterans Syndrome 2 Tumor Lysis Syndrome 1 Solid Tumors 1 Recurrence 1 Oncology Patients Receiving Chemotherapy 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia, Prolymphocytic, B-Cell 1 Leukemia, Lymphoid 1 Leukemia, Hairy Cell 1 Indolent Non-Hodgkin's Lymphoma 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1 B-cell Malignancies 1 Anemia 1

Interventions

blinatumomab 6 Rituximab 4 Cyclophosphamide 4 Tacrolimus 3 ponatinib 2 fludarabine 2 denileukin diftitox 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Cytarabine 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 Alemtuzumab 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibrutinib 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡